Kilitch Drugs reports Q2 2025 financial results

Kilitch Drugs (India) Ltd. has announced its financial results for the quarter ended September 30, 2025. The company's management submitted an extract of these financial results to both the BSE Limited and the National Stock Exchange of India Ltd. on November 15, 2025. The results were also published in Marathi and English newspaper editions on the same date.

The announcement was signed by Mukund Mehta, the managing director of Kilitch Drugs (India) Limited. The company's corporate office is in Mumbai, India, and it operates a registered office and manufacturing unit in Navi Mumbai, Maharashtra. Kilitch Drugs (India) Ltd. is ISO 9001:2008 and 13485:2003 certified and is recognized as an Export House of India.

The company's communication confirmed the submission of the required newspaper publications, requesting that the receipt be acknowledged by the respective stock exchanges. This release ensures compliance with regulatory requirements regarding the dissemination of financial performance data.